期刊文献+

不同糖代谢状态人群血浆可溶性CD36水平及相关因素研究 被引量:2

Levels of Plasma Soluble CD36 and Its Related factors in Individuals in Different Status of Glucose Metabolism
下载PDF
导出
摘要 目的评价不同糖代谢状态人群血浆可溶性CD36(sCD36)水平的差异,分析sCD36与炎性反应、血糖、血脂等指标的相关性。方法 2011年3月—2012年1月选取上海市浦东新区川沙、合庆及机场镇3个社区的居民234例,根据75 g葡萄糖耐量试验分为正常糖耐量组(NGT组,n=121),糖调节异常组(IGR组,n=69)及初发糖尿病组(NDM组,n=44)。比较3组受试者的体质指数(BMI)、腰臀比(WHR)、空腹血糖(FPG)及口服葡萄糖后2 h血糖(2 hPG)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)、糖化血红蛋白(HbA1c)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、sCD36、超敏C反应蛋白(hs-CRP)。结果 IGR组与NDM组高血压病史发生率高于NGT组,BMI、WHR、收缩压(SBP)、舒张压(DBP)高于NGT组(P<0.05)。3组sCD36、hs-CRP、HOMA-IR、HbA1c、FPG、2 hPG、血肌酐(Scr)、TG、LDL-C逐渐升高(P<0.05),HDL-C逐渐降低(P<0.05)。血浆sCD36与WHR、FPG、2 hPG、HbA1c、hs-CRP及log10(TG)呈正相关(r=0.230、0.273、0.267、0.178、0.254、0.142,P<0.05),与性别呈负相关(男=1,女=2)(r=-0.213,P<0.05)。多元回归分析显示,FPG(标准化偏回归系数=0.204,P=0.002)、男性(标准化偏回归系数=-0.175,P=0.007)和hs-CRP(标准化偏回归系数=0.156,P=0.017)是sCD36升高的独立影响因素。结论不同糖代谢状态人群血浆sCD36水平存在显著差异,其水平与炎性反应及糖尿病的发生密切相关。 Objective To evaluate levels of plasma soluble CD36 (sCD36) in individuals in different status of glucose metabolism, and analyze the correlation of sCD36 with inflammatory reactions, blood glucose and blood lipids. Methods From March 2011 to January 2012, a total of 234 subjects in Shanghai Chuansha, Heqing, and Airport community, were divided according to 75 g oral glucose tolerance test (OGTT), into groups of normal glucose tolerance (NGT group, n = 121 ), impaired glucose regulation ( IGR group, n = 69 ), new diabetes mellitus ( NDM, n = 44). The body mass index ( BMI), waist - hip ratio (WHR), fasting plasma glucose (FPG), postprandial 2 h glucose (2 hPG), fasting insulin (FINS), insulin resistance index ( HOMA - IR), glycosylated hemoglobin ( HbA,o ), total cholesterol ( TC), triglyceride ( TG), high density lipoprotein cholesterol ( HDL - C ), low density lipoprotein cholesterol ( LDL - C), sCD36, high - sensitivity C - reactive protein (hs - CRP). Results NDM group and IGR group had high incidence of hypertension, higher BMI, WHR, SBP, DBP than NGTgproup (P〈0. 05). Levels of sCD36, hs-CRP, HOMA-IR, HbAlc, FPG, 2 bPG, Scr, TG, LDL-C increased, and HDL - C decreased in 3 groups ( P 〈 0.05 ). Plasma sCD36 was positively correlated with WHR, FPG, 2 hPG, HbAIo, hs-CRP, log10 (TG) (r=0.230, 0.273, 0.267, 0.178, 0.254, 0.142, P〈0.05), negatively with gender (males = 1, females =2) (r=-0.213, P〈0.05). Multiple regression analysis showed that FPG (β=0.204, P=0.002), males (β = -0. 175, P = 0. 007 ), hs- CRP (β= 0. 156, P = 0. 017 ) were independent influencing factors of increased sCD361 Conchmion There is difference in sCD36 level between individuals in different status of glucose metabolism, which is closely related to inflammatory reaction and occurrence of diabetes.
出处 《中国全科医学》 CAS CSCD 北大核心 2014年第20期2337-2340,共4页 Chinese General Practice
基金 上海市卫生局科研课题(2009214) 上海市卫生局青年科研项目(2010Y047) 上海市浦东新区优秀青年人才培养计划(PWRq2012-09) 上海市浦东新区卫生局青年科研项目(PW2010B-6)
关键词 糖尿病 2型 糖调节异常 可溶性CD36 炎性反应 Diabetes mellitus, type 2 Impaired glucose regulation Soluble CD36 Inflammation
  • 相关文献

参考文献8

  • 1Handberg A, Levin K, H:jlund K, et al. Identification of the oxidized low - density lipoprotein scavenger receptor cd36 in plasma a novel mark-er of insulin resistance [J]. Circulation, 2006, 114 (11) : 1169 - 1176.
  • 2Handberg A, Skjelland M, Miehelsen AE, et al. Soluble CD36 in plasma is increased in patients with symptomatic atheroselerotie carotid plaques and is related to plaque instability [ J ]. Stroke, 2008, 39 (11) : 3092 -3095.
  • 3Handberg A, Norberg M, Stenlund H, et al. Soluble CD36 (sCD36) dusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk [J]. Journal of Clinical Endocrinol- ogy & Metabolism, 2010, 95 (4) : 1939- 1946.
  • 4Handberg A, Hcjlund K, Gastaldelli A, et al. Plasma sCD36 is asso- ciated with markers of athemselemsis, insulin resistance and fatty liver in a nondiabetie healthy population [ J ]. Journal of Internal Medicine, 2012, 271 (3): 294-304.
  • 5Glintborg D, Hcjlund K, Andersen M, et al. Soluble CD36 and risk markers of insulin resistance and athemselemsis are elevated in polyeystie ovary syndrome and significantly reduced during pioglitazone treatment [J]. Diabetes Care, 2008, 31 (2): 328-334.
  • 6Handberg A, Lopez -Bermejo A, Bassols J, et al. Circulating soluble CD36 is associated with glucose metabolism and interleukin -6 in glu- cose -intolerant men [J]. Diabetes & Vascular Disease Research: Of- fieial Journal of the International Society of Diabetes and Vascular Dis- ease, 2009, 6 (1): 15-20.
  • 7Van Greevenbroek MM, Schalkwijk CG, Stehouwer CD. Obesity - as- sociated low - grade inflammation in type 2 diabetes mellitus : causes and consequences [J],The Netherlands Journal of Medicine, 2013, 71 (4) : 174 - 187.
  • 8张晓菲,庞翠军,肖常青.不同性别2型糖尿病患者分泌型CD36水平变化及颈动脉内膜中层厚度的影响因素研究[J].中国全科医学,2012,15(2):179-181. 被引量:1

二级参考文献15

  • 1Handberg A,Skjelland M,Ae M,et al.Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability[J].Stroke,2008,39:3092-3095.
  • 2Li Wang,Yi Bao,Yuan Yang,et al.Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay[J].Journal of Biomolecular Screening,2010,15(3):239-250.
  • 3Hoosdally SJ,Andress EJ,Wooding C,et al.The human scavenger receptor CD36:glycosylation status and its role in trafficking and function[J].Biol Chem,2009,284:16277-16288.
  • 4Silverstein RL,Li W,Park YM,et al.Mechanisms of cell signaling by the scavenger receptor CD36:implications in atherosclerosis and thrombosis[J].Trans Am Clin Climatol Assoc,2010,121:206-220.
  • 5Hansson GK.Inflammation,atherosclerosis,and coronary artery disease[J].New Engl Med,2005,352:1685-1695.
  • 6Xianthis A,Hatzitolios A,Fidani S,et al.Receptor of advanced glycation end products(RAGE) positively regulate CD36 expression and reaction oxygen spaces production in human monocytes in diabetes[J].Angiology,2009,60:772-779.
  • 7Graessler J,Pietzsch J,Westendorf T,et al.Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator-activator receptor γ gene expression in macrophages[J].Diabetologia,2007,50:1080-1088.
  • 8Handberg A,Lopez-bermejo A,Bassols J,et al.Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men[J].Diabetes Vasc Dis Res,2009,6:15-20.
  • 9Handberg A,Skjelland M,Michelsen AE,et al.Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability[J].Stroke,2008,39:3092-3095.
  • 10Chedraui P,Pérez-López FR,Blümel JE,et al.Hyperglycemia in postmenopausal women screened for the metabolic syndrome is associated to increased sexual complaints[J].Gynecol Endocrinol,2010,26(2):86-92.

同被引文献23

  • 1Peng YF, Cao L, Zeng YH, et aI. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in patients with rheumatoidarthritis[J]. Open Med, 2015, 10: 2(1): 49-253. DOI: 10.1515/ med -2015 -0037.
  • 2Ge Y, Elghetany MT. CD36: a multiligand molecule[J]. Lab Hematol, 2005,11 ( 1 ) : 31-37.
  • 3Collot-Teixeira S, Martin J, McDermott-Roe C, et al. CD36 and macrophages in atherosclerosis[J]. Cardiovasc Res, 2007, 75 (3) : 468-477. DOI: 10.1016/j.cardiores.2007.03.010.
  • 4Feng J, Han J, Pearce SF, et al. Induction of CD36 expression by oxidized LDL and IL-4 by acommon signaling pathway de- pendent on protein kinase C and PPAR-gamma[J]. J Lipid Res, 2000, 41: 688-696.
  • 5Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classifiation of rheumatoid arthritis[J]. Arthritis Rhemn, 1988, 31 (3): 315- 324.
  • 6Nergiz-Unal R, Rademakers T, Cosemans JM, et al. CD36 as a multiple-ligand signaling receptor in atherothrombosis [J]. Cardiovasc Hematol Agents Med Chem, 2011, 9(1 ): 42-55. DOI: 10. 2174/187152511794182855.
  • 7Silverstein RL, Febbraio M. CD36, a scavenger recepto rin- volved in immunity, metabolism, angiogenesis, and behavior[J]. Sci Signal, 2009, 2 (72): 12-31. DOI: 10.1126/scisignal.272 fe3.
  • 8Hashizume M, Mihara M. Blockade of IL-6 and TNF-α inhibited oxLDL-induced production of MCP-1 via scavenger receptor in-duction[J]. Eur J Pharmacol, 2012, 689: 249-254. DOI: 10. 1016/j.ejphar.2012.05.03 5.
  • 9Chung EY, Liu J, Homma Y, et al. Interleukin-10 expression in macrophagesduring phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbxl and Prep-l[J]. Immunity, 2007, 27: 952-964. DOI : http ://dx.doi.org/10.1016/j.immuni.2007.11.014.
  • 10Bottcher A, Gaipl US, Furnrohr BG, et al. Involvement of phos- phatidylserine,alphavbeta3, CD14, CD36, and complement Clq in the phagocytosis of primarynecrotic lymphocytes by macro- phages[J]. Arthritis Rheum, 2006, 54(3): 927-938. DOI: 10. 1002/art.21660.

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部